We are live on ! Find out more
BF

BOK Financial Portfolio holdings

AUM $6.54B
1-Year Est. Return 25.41%
This Fund
S&P 500
This Quarter Est. Return
+20.8%
1 Year Est. Return
+25.41%
3 Year Est. Return
+74.09%
5 Year Est. Return
10 Year Est. Return
AUM
$4.25B
AUM Growth
+$781M
Cap. Flow
+$120M
Cap. Flow %
2.83%
Top 10 Hldgs %
23.64%
Holding
909
New
85
Increased
394
Reduced
329
Closed
60

Top Buys

Rank Stock Value
1
IWL icon
iShares Russell Top 200 ETF
IWL
+$45.9M
2
MSFT icon
Microsoft
MSFT
+$9.16M
3
ABBV icon
AbbVie
ABBV
+$5.26M
4
AMZN icon
Amazon
AMZN
+$4.52M
5
DOW icon
Dow Inc
DOW
+$4.01M

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Healthcare 10.93%
3 Financials 8.8%
4 Industrials 6.74%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
201
L3Harris
LHX
$50.9B
$4.49M 0.11%
26,467
+1,941
+8% +$365K
YUM icon
202
Yum! Brands
YUM
$42.6B
$4.49M 0.11%
51,628
-5,453
-10% -$466K
ETN icon
203
Eaton
ETN
$155B
$4.24M 0.1%
48,493
+191
+0.4% +$15.7K
VIG icon
204
Vanguard Dividend Appreciation ETF
VIG
$111B
$4.19M 0.1%
35,761
-1,581
-4% -$180K
MU icon
205
Micron Technology
MU
$975B
$4.18M 0.1%
81,213
-3,416
-4% -$161K
TJX icon
206
TJX Companies
TJX
$175B
$4.17M 0.1%
82,441
-15,613
-16% -$784K
NVS icon
207
Novartis
NVS
$297B
$4.03M 0.09%
46,186
+7,626
+20% +$658K
XYL icon
208
Xylem
XYL
$27B
$4.01M 0.09%
61,743
-2,609
-4% -$172K
HRC
209
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4M 0.09%
36,468
+7,396
+25% +$774K
REGN icon
210
Regeneron Pharmaceuticals
REGN
$76.3B
$3.93M 0.09%
6,299
-77
-1% -$43.7K
MXIM
211
DELISTED
Maxim Integrated Products
MXIM
$3.88M 0.09%
64,041
-5,072
-7% -$282K
MTD icon
212
Mettler-Toledo International
MTD
$29.1B
$3.85M 0.09%
4,786
-372
-7% -$277K
ZEN
213
DELISTED
ZENDESK INC
ZEN
$3.82M 0.09%
43,139
+12,954
+43% +$997K
PNC icon
214
PNC Financial Services
PNC
$99.3B
$3.8M 0.09%
36,089
+977
+3% +$103K
GLW icon
215
Corning
GLW
$121B
$3.77M 0.09%
145,593
-23,478
-14% -$532K
GSK icon
216
GSK
GSK
$104B
$3.75M 0.09%
73,487
+14,036
+24% +$720K
LIN icon
217
Linde
LIN
$221B
$3.72M 0.09%
17,554
+1,226
+8% +$237K
SRPT icon
218
Sarepta Therapeutics
SRPT
$1.62B
$3.72M 0.09%
23,222
-1,013
-4% -$138K
AXP icon
219
American Express
AXP
$228B
$3.69M 0.09%
38,810
+7,803
+25% +$718K
NOC icon
220
Northrop Grumman
NOC
$75.8B
$3.69M 0.09%
11,986
-603
-5% -$198K
IDXX icon
221
Idexx Laboratories
IDXX
$43.7B
$3.68M 0.09%
11,141
-185
-2% -$53.6K
GWW icon
222
W.W. Grainger
GWW
$64.9B
$3.66M 0.09%
11,642
-349
-3% -$101K
HDS
223
DELISTED
HD Supply Holdings, Inc.
HDS
$3.63M 0.09%
104,716
+1,054
+1% +$32.7K
LAMR icon
224
Lamar Advertising Co
LAMR
$16.2B
$3.63M 0.09%
54,320
+37,986
+233% +$2.32M
IGIB icon
225
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
$3.6M 0.08%
59,607
+12,065
+25% +$703K

Similar funds

BOK Financial's Q2 2020 Portfolio in Review

As of Q2 2020, BOK Financial held 909 positions worth $4.25B, up 22% from $3.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

BOK Financial's Q2 2020 filing shows 85 new, 394 increased, 329 reduced and 60 closed positions. Its largest new stake was iShares Russell Top 200 ETF: 656,150 shares worth $48.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • BOK Financial's largest Q2 2020 buy was iShares Russell Top 200 ETF: 656,150 shares worth $48.6M.
  • BOK Financial added most to Microsoft in Q2 2020, an estimated $9.16M increase.
  • BOK Financial's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $18.9M.
  • BOK Financial fully exited Vanguard FTSE Pacific ETF in Q2 2020, selling an estimated $6.69M.
  • BOK Financial's ten largest holdings make up 24% of its $4.25B portfolio in Q2 2020.
  • BOK Financial opened 85 new positions and closed 60 in Q2 2020.
  • BOK Financial's portfolio value rose 22% quarter-over-quarter to $4.25B.

Based on BOK Financial's 13F filing for Q2 2020, filed 12 Aug 2020.